Carboplatin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Carboplatin and local guidelines before prescribing.

Platinum cytotoxic

Mechanism

Platinum compound forming DNA crosslinks.

Uses

Ovarian, lung, head and neck, germ cell tumours.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Myelosuppression (thrombocytopenia), nausea, nephrotoxicity less than cisplatin.

Interactions

Aminoglycosides raise nephro- and ototoxicity risk.

Contraindications and cautions

Severe marrow suppression, severe renal impairment

Monitoring

FBC, U&E

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Dose by GFR

Overdose and reversal

Supportive

Special advice

Dose by renal function (Calvert formula); FBC before each cycle.

More from the textbook: uses, cautions and other points
Where it is discussed in the book